Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New use of anti-impaludism medicament hydroxyl chloroquine

A technology of hydroxychloroquine and new use, applied in the new use field of antimalarial drug hydroxychloroquine, can solve problems such as incurability

Inactive Publication Date: 2009-05-13
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF0 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, MM is incurable, but its survival is highly heterogeneous (a few weeks to more than 10 years)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New use of anti-impaludism medicament hydroxyl chloroquine
  • New use of anti-impaludism medicament hydroxyl chloroquine
  • New use of anti-impaludism medicament hydroxyl chloroquine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] In order to better understand the essence of the present invention, the following experiments and results will be used to further illustrate the killing activity of multiple myeloma cells by hydroxychloroquine enhancing doxorubicin and other conventional chemotherapy drugs and its mechanism. It should be noted that the following examples are only used to illustrate the implementation of the present invention, and do not limit the implementation scope of the present invention.

[0018] 1. Experimental reagents and cells

[0019] Human myeloma cell line H929 was cultured in RPMI1640 medium with 10% fetal bovine serum in 5% CO 2 , 10% fetal bovine serum, saturated humidity, cultured in a 37°C incubator, subcultured once every 2-3 days, and the cells were in the exponential growth phase during the experiment. Hydroxychloroquine (0.1 / tablet) (product of Shanghai Zhongxi Pharmaceutical Co., Ltd.), fully dissolved in water for injection, centrifuged at 12,000 rpm, subpackaged...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the novel usage of an antimalarial medicine, in particular to the novel usage of hydroxychloroquine having sensitivity enhancing effect on various chemical anti-multiple myeloma medicaments. The novel usage is characterized in the application of hydroxychloroquine in treatment of multiple myeloma through chemotherapeutic medicaments. The hydroxychloroquine can obviously enhance the killing activity of chemotherapeutic medicines such as doxorubicine, epidoxorubicin, cis-platinum and mitoxantrone to multiple myeloma cells, and the killing activity thereof is realized by inhibiting the myeloma cell autophagy signals by hydroxychloroquine. Hydroxychloroquine can induce the quantity of the autophagy lysosomes of the multiple myeloma cells to be increased and the expression of the autophagy-associated albumen LC3-II to be increased.

Description

technical field [0001] The invention relates to a new application of an antimalarial drug, in particular to a new application of hydroxychloroquine which has a sensitizing effect on various chemical anti-multiple myeloma drugs. Background technique [0002] Multiple myeloma (MM) is a lethal malignant plasma cell tumor derived from memory B cells or plasma cells, mainly affecting the elderly, with a median age of onset of 60 years. Clinically, MM is incurable, but its survival is highly heterogeneous (several weeks to more than 10 years). In view of the fact that the most critical factor affecting the survival of MM is the formation of drug resistance, it is necessary to continuously search for and develop specific and efficient drug resistance reversal agents aimed at the drug resistance mechanism of tumor cells. The survival period is particularly important. Contents of the invention [0003] The purpose of the present invention is to provide a new application of antima...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4706A61P35/00
Inventor 陈协群高广勋顾宏涛潘耀柱高瑛
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com